Suchocki P - Search Results

1

Selol (Se IV) modulates adhesive molecules in control and TNF-α-stimulated HMEC-1 cells.

Grosicka-Maciąg E, Kurpios-Piec D, Woźniak K, Kowalewski C, Szumiło M, Drela N, Kiernozek E, Suchocki P, Rahden-Staroń I. Grosicka-Maciąg E, et al. Among authors: suchocki p. J Trace Elem Med Biol. 2019 Jan;51:106-114. doi: 10.1016/j.jtemb.2018.10.005. Epub 2018 Oct 5. J Trace Elem Med Biol. 2019. PMID: 30466918

2

Evaluation of mutagenic activity of the organo-selenium compound Selol by use of the Salmonella typhimurium mutagenicity assay.

Rahden-Staroń I, Suchocki P, Czeczot H. Rahden-Staroń I, et al. Among authors: suchocki p. Mutat Res. 2010 Jun 17;699(1-2):44-6. doi: 10.1016/j.mrgentox.2010.04.018. Epub 2010 Apr 24. Mutat Res. 2010. PMID: 20417718

3

Changes in antioxidant defense systems induced by thiram in V79 Chinese hamster fibroblasts.

Grosicka-Maciag E, Kurpios D, Czeczot H, Szumiło M, Skrzycki M, Suchocki P, Rahden-Staroń I. Grosicka-Maciag E, et al. Among authors: suchocki p. Toxicol In Vitro. 2008 Feb;22(1):28-35. doi: 10.1016/j.tiv.2007.07.006. Epub 2007 Jul 26. Toxicol In Vitro. 2008. PMID: 17728093

4

The activity of Selol in multidrug-resistant and sensitive human leukemia cells.

Suchocki P, Misiewicz I, Skupinska K, Waclawek K, Fijalek Z, Kasprzycka-Guttman T. Suchocki P, et al. Oncol Rep. 2007 Oct;18(4):893-9. Oncol Rep. 2007. PMID: 17786352

5

Effects of Selol 5% supplementation on tissue antioxidant enzyme levels and peroxidation marker in healthy mice.

Sochacka M, Giebułtowicz J, Remiszewska M, Suchocki P, Wroczyński P. Sochacka M, et al. Among authors: suchocki p. Pharmacol Rep. 2018 Dec;70(6):1073-1078. doi: 10.1016/j.pharep.2018.06.003. Epub 2018 Jun 18. Pharmacol Rep. 2018. PMID: 30296743

6

The influence of Selol on the expression of oxidative stress genes in normal and malignant prostate cells.

Ksiazek I, Sitarz K, Roslon M, Anuszewska E, Suchocki P, Wilczynska JD. Ksiazek I, et al. Among authors: suchocki p. Cancer Genomics Proteomics. 2013 Sep-Oct;10(5):225-32. Cancer Genomics Proteomics. 2013. PMID: 24136975

7

Toxicity studies of a new selenium compound, Selol, in rats.

Jastrzebski Z, Czyzewska-Szafran H, Fijatek Z, Suchocki P, Fitak BA. Jastrzebski Z, et al. Among authors: suchocki p. Drugs Exp Clin Res. 1995;21(6):217-20. Drugs Exp Clin Res. 1995. PMID: 8907696

8

Comparison of selected gene expression profiles in sensitive and resistant cancer cells treated with doxorubicin and Selol.

Dudkiewicz-Wilczyńska J, Grabowska A, Książek I, Sitarz K, Suchocki P, Anuszewska E. Dudkiewicz-Wilczyńska J, et al. Among authors: suchocki p. Contemp Oncol (Pozn). 2014;18(2):90-4. doi: 10.5114/wo.2014.40558. Epub 2014 Jun 3. Contemp Oncol (Pozn). 2014. PMID: 24966790 Free PMC article.

9

Decoration of a Poly(methyl vinyl ether-co-maleic anhydride)-Shelled Selol Nanocapsule with Folic Acid Increases Its Activity Against Different Cancer Cell Lines In Vitro.

Ganassin R, Souza LR, Py-Daniel KR, Longo JPF, Coelho JM, Rodrigues MC, Jiang CS, Gu J, Morais PC, Mosiniewicz-Szablewska E, Suchocki P, Báo SN, Azevedo RB, Muehlmann LA. Ganassin R, et al. Among authors: suchocki p. J Nanosci Nanotechnol. 2018 Jan 1;18(1):522-528. doi: 10.1166/jnn.2018.13974. J Nanosci Nanotechnol. 2018. PMID: 29768877

10

Effects of Selol 5% supplementation on the activity or concentration of antioxidants and malondialdehyde level in the blood of healthy mice.

Sochacka M, Giebułtowicz J, Remiszewska M, Suchocki P, Wroczyński P. Sochacka M, et al. Among authors: suchocki p. Pharmacol Rep. 2014 Apr;66(2):301-10. doi: 10.1016/j.pharep.2013.10.004. Epub 2014 Mar 4. Pharmacol Rep. 2014. PMID: 24911085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page